Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adicet Bio Inc (NQ: ACET )

1.250 -0.030 (-2.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Adicet Bio Inc

< Previous 1 2 3 4 Next >
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Via Benzinga
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news 
Via InvestorPlace
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023
ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Adicet Bio: Q4 Earnings Insights
Via Benzinga
Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know
Via Benzinga
6 Analysts Have This to Say About Adicet Bio
Via Benzinga
3 High-Risk Stocks That Could Pay Off in the Millions
With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Top-Tier Penny Stocks for a Smart Bet
Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers 
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these... 
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
Via Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
Why Are Gamma-Delta T Cells Important In Fighting Cancer? 
Via Benzinga
Analyst Downgrades Adicet Citing Uncertainty, Awaits Long-Term Data On Durability
JMP Securities downgraded Adicet Bio Inc (NASDAQ: ACET) to a Market Perform (from Market Outperform) and removed the  
Via Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42.... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
Dow Up Triple Digits As Consumer Confidence Increases
Stocks are on the rise this afternoon. 
Via Talk Markets
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
Via Benzinga
US Stocks Higher; Durable Goods Orders Top Estimates
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% to 33,780.40 while the NASDAQ rose... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.